Alvotech Reports Mixed Fortunes: Revenue Rises, But Stock Dips Amid FDA Concerns
Alvotech, Iceland’s largest pharmaceutical company by revenue, is currently navigating a challenging period. The company specialises in developi...
Global Opportunities for Icelandic Business at Annual Enterprise Meeting
At the Annual Meeting of the Confederation of Icelandic Enterprise (Samtök atvinnulífsins), Róbert Wessman, Founder and Executive Chairman of Alvotech...
Alvotech Begins Trading on Nasdaq Stockholm, Expands Nordic Presence
Alvotech, the Icelandic biopharmaceutical company specialising in developing and manufacturing biosimilar medicines, began trading today on Nasdaq Sto...
Alvotech Poised for Rapid Growth Following Nasdaq Listing
Alvotech, the Icelandic biopharmaceutical company specialising in biosimilars, is anticipating significant growth following its recent listing on the ...
Alvotech and STADA Pave Way partner together
Alvotech, an Iceland-based global biopharmaceutical company, has announced that all intellectual property disputes with AbbVie related to its AVT02 bi...